LITTLE KNOWN FACTS ABOUT MBL77.

Not all people with CLL demand therapy. Irrespective of all the latest innovations, the iwCLL nevertheless suggests watchful observation for sufferers with asymptomatic condition.86 This suggestion relies on not less than two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (F